Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection

Trends in Immunology

Volumn 37, Issue 2, 2016, Pages 126-140

  Fodil, Nassima ^a   Langlais, David ^a   Gros, Philippe ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INFECTION; INFLAMMATORY DISEASE; MOLECULAR PATHOLOGY; REVIEW; ANIMAL; AUTOIMMUNE DISEASE; EXOME; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; MUTATION; RISK;

ANIMALS; AUTOIMMUNE DISEASES; EXOME; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MUTATION; RISK;

EID: 84983097926     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.12.006     Document Type: Review

References (87)

1. 1 Newport, M.J., Finan, C., Genome-wide association studies and susceptibility to infectious diseases. Brief Funct. Genomics 10 (2011), 98–107.
2. 2 Khor, C.C., Hibberd, M.L., Host-pathogen interactions revealed by human genome-wide surveys. Trends Genet. 28 (2012), 233–243.
3. 3 Vannberg, F.O., et al. Human genetic susceptibility to intracellular pathogens. Immunol. Rev. 240 (2011), 105–116.
4. 4 Aidoo, M., et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359 (2002), 1311–1312.
5. 5 Dean, M., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 (1996), 1856–1862.
6. 6 Picard, C., Fischer, A., Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur. J. Immunol. 44 (2014), 2854–2861.
7. 7 Chou, J., et al. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Curr. Opin. Allergy Clin. Immunol. 12 (2012), 623–628.
8. 8 Conley, M.E., Casanova, J.L., Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr. Opin. Immunol. 30 (2014), 17–23.
9. 9 Delogu, L.G., et al. Infectious diseases and autoimmunity. J. Infect. Dev. Ctries. 5 (2011), 679–687.
10. 10 Parkes, M., et al. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14 (2013), 661–673.
11. 11 Anderson, C.A., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43 (2011), 246–252.
12. 12 Franke, A., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42 (2010), 1118–1125.
13. 13 Jostins, L., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
14. 14 Okada, Y., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 (2014), 376–381.
15. 15 Tsoi, L.C., et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44 (2012), 1341–1348.
16. 16 Ellinghaus, E., et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat. Genet. 42 (2010), 991–995.
17. 17 International Multiple Sclerosis Genetics Consortium, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476 (2011), 214–219.
18. 18 International Multiple Sclerosis Genetics Consortium, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45 (2013), 1353–1360.
19. 19 Chapman, S.J., Hill, A.V., Human genetic susceptibility to infectious disease. Nat. Rev. Genet. 13 (2012), 175–188.
20. 20 Karlsson, E.K., et al. Natural selection and infectious disease in human populations. Nat. Rev. Genet. 15 (2014), 379–393.
21. 21 Abel, L., et al. The dissection of complex susceptibility to infectious disease: bacterial, viral and parasitic infections. Curr. Opin. Immunol. 30 (2014), 72–78.
22. 22 Milner, J.D., Holland, S.M., The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat. Rev. Immunol. 13 (2013), 635–648.
23. 23 Parvaneh, N., et al. Inborn errors of metabolism underlying primary immunodeficiencies. J. Clin. Immunol. 34 (2014), 753–771.
24. 24 Itan, Y., Casanova, J.L., Novel primary immunodeficiency candidate genes predicted by the human gene connectome. Front. Immunol., 6, 2015, 142.
25. 25 Al-Herz, W., et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front. Immunol., 5, 2014, 162.
26. 26 Casanova, J.L., et al. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J. Exp. Med. 211 (2014), 2137–2149.
27. 27 Rieux-Laucat, F., Casanova, J.L., Immunology. Autoimmunity by haploinsufficiency. Science 345 (2014), 1560–1561.
28. 28 Boisson, B., et al. Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind. Curr. Opin. Immunol. 32 (2015), 90–105.
29. 29 Anderson, M.S., Casanova, J.L., More than meets the eye: monogenic autoimmunity strikes again. Immunity 42 (2015), 986–988.
30. 30 Fischer, A., et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203 (2005), 98–109.
31. 31 Song, E., et al. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin. Mol. Allergy, 9, 2011, 10.
32. 32 Zhang, S.Y., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317 (2007), 1522–1527.
33. 33 Zhang, S.Y., et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol. Rev. 226 (2008), 29–40.
34. 34 Puel, A., et al. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr. Opin. Allergy Clin. Immunol. 12 (2012), 616–622.
35. 35 Bustamante, J., et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin. Immunol. 26 (2014), 454–470.
36. 36 Dupuis, S., et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293 (2001), 300–303.
37. 37 Liu, L., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208 (2011), 1635–1648.
38. 38 Devriendt, K., et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat. Genet. 27 (2001), 313–317.
39. 39 Hahn, C.N., et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43 (2011), 1012–1017.
40. 40 Hsu, A.P., et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118 (2011), 2653–2655.
41. 41 Dickinson, R.E., et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118 (2011), 2656–2658.
42. 42 Minegishi, Y., et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25 (2006), 745–755.
43. 43 Kreins, A.Y., et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J. Exp. Med. 212 (2015), 1641–1662.
44. 44 Hindorff, L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 9362–9367.
45. 45 Li, M.J., et al. GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Res. 40 (2012), D1047–D1054 (Database issue).
46. 46 Webb, A.J., et al. An informatics project and online ‘Knowledge Centre’ supporting modern genotype-to-phenotype research. Hum. Mutat. 32 (2011), 543–550.
47. 47 Thorisson, G.A., et al. HGVbaseG2P: a central genetic association database. Nucleic Acids Res. 37 (2009), D797–D802 (Database issue).
48. 48 Farh, K.K., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518 (2015), 337–343.
49. 49 Cortes, A., Brown, M.A., Promise and pitfalls of the Immunochip. Arthritis Res. Ther., 13, 2011, 101.
50. 50 Siddle, K.J., Quintana-Murci, L., The Red Queen's long race: human adaptation to pathogen pressure. Curr. Opin. Genet. Dev. 29 (2014), 31–38.
51. 51 Blaydon, D.C., et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 365 (2011), 1502–1508.
52. 52 Cheng, L.E., et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin. Immunol. 132 (2009), 124–131.
53. 53 Mizukami, T., et al. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J. Clin. Immunol. 32 (2012), 39–49.
54. 54 Aguilar, C., et al. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J. Allergy Clin. Immunol. 134 (2014), 1131–1141.
55. 55 Dziadzio, M., et al. Symptomatic males and female carriers in a large caucasian kindred with XIAP deficiency. J. Clin. Immunol. 35 (2015), 439–444.
56. 56 Yang, X., et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J. Clin. Immunol. 32 (2012), 411–420.
57. 57 Zeissig, Y., et al. XIAP variants in male Crohn's disease. Gut 64 (2015), 66–76.
58. 58 Conley, M.E., et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K. J. Exp. Med. 209 (2012), 463–470.
59. 59 Salzer, E., et al. Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency. J. Allergy Clin. Immunol. 133 (2014), 1651–1659.
60. 60 Avitzur, Y., et al. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 146 (2014), 1028–1039.
61. 61 Chen, R., et al. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. J. Allergy Clin. Immunol. 132 (2013), 656–664.
62. 62 Okou, D.T., et al. Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 58 (2014), 561–568.
63. 63 Dhillon, S.S., et al. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology 147 (2014), 680–689.
64. 64 Zhou, Q., et al. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cgamma2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91 (2012), 713–720.
65. 65 Zeissig, S., et al. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. Gut 64 (2014), 1889–1897.
66. 66 Glocker, E.O., et al. Infant colitis-–it's in the genes. Lancet, 376, 2010, 1272.
67. 67 Glocker, E.O., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361 (2009), 2033–2045.
68. 68 Kotlarz, D., et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 143 (2012), 347–355.
69. 69 Moran, C.J., et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel Dis. 19 (2013), 115–123.
70. 70 Bentham, J., et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47 (2015), 1457–1464.
71. 71 Jin, Y., et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat. Genet. 44 (2012), 676–680.
72. 72 Todd, J.A., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39 (2007), 857–864.
73. 73 Ferreira, R.C., et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat. Genet. 42 (2010), 777–780.
74. 74 Sutherland, A., et al. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves’ disease susceptibility. J. Clin. Endocrinol. Metab. 92 (2007), 3338–3341.
75. 75 Genetic Analysis of Psoriasis, C., et al. A., genome-wide association study identifies new psoriasis susceptibility loci and an interaction between, HLA-C., and, ERAP1. Nat. Genet. 42 (2010), 985–990.
76. 76 Kennedy, J.M., et al. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation. J. Exp. Med. 211 (2014), 2519–2535.
77. 77 Funabiki, M., et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40 (2014), 199–212.
78. 78 Nejentsev, S., et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324 (2009), 387–389.
79. 79 Cen, H., et al. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 46 (2013), 455–462.
80. 80 Gateva, V., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41 (2009), 1228–1233.
81. 81 Molineros, J.E., et al. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet., 9, 2013, e1003222.
82. 82 Loo, Y.M., Gale, M. Jr, Immune signaling by RIG-I-like receptors. Immunity 34 (2011), 680–692.
83. 83 Pestal, K., et al. Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity 43 (2015), 933–944.
84. 84 Rice, G.I., et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46 (2014), 503–509.
85. 85 Oda, H., et al. Aicardi-Goutieres syndrome is caused by IFIH1 mutations. Am. J. Hum. Genet. 95 (2014), 121–125.
86. 86 Fairfax, B.P., et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science, 343, 2014, 1246949.
87. 87 Salem, S., et al. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation. Blood 124 (2014), 1894–1904.